SCHEMBL4019567

SCHEMBL4019567

CC(C)(C)[S+]([O-])NC(CO[Si](C)(C)C(C)(C)C)c1ccc(F)cn1

nearest known ligand 0.30

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
HDAC6 Q9UBN7 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1693207 1.00 HDAC6 (0.30) HDAC6
SCHEMBL3015031 1.00 HDAC6 (0.30) HDAC6
SCHEMBL1439307 1.00 HDAC6 (0.30) HDAC6
SCHEMBL30178687 0.86
SCHEMBL25603324 0.83
SCHEMBL30178600 0.83
SCHEMBL25603320 0.83
SCHEMBL25603329 0.83
SCHEMBL17688660 0.82
SCHEMBL17688598 0.82

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009095712-A2 CHEMICAL COMPOUNDS ASTRAZENECA AB (SE) 2009-08-06 WO disclosed
WO-2009016410-A2 CHEMICAL COMPOUNDS 831 ASTRAZENECA AB (SE) 2009-02-05 WO disclosed
WO-2008132502-A1 PYRAZOLYL-AMINO-SUBSTITUTED PYRIMIDINES AND THEIR USE FOR THE TREATMENT OF CANCER ASTRAZENECA AB (SE) 2008-11-06 WO disclosed